Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

IMPORTANCE: Men with type 2 diabetes have an increased risk of cardiovascular disease (CVD). Meanwhile, gonadotropin-releasing hormone (GnRH) agonists used in prostate cancer (PCa) are associated with increased risk of CVD. OBJECTIVE: To evaluate the association between GnRH agonist use, PCa diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, E., Garmo, Hans, Van Hemelrijck, Mieke, Zethelius, Björn, Stattin, Pär, Hagström, Emil, Adolfsson, Jan, Crawley, Danielle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361086/
https://www.ncbi.nlm.nih.gov/pubmed/35939302
http://dx.doi.org/10.1001/jamanetworkopen.2022.25600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361086/
https://www.ncbi.nlm.nih.gov/pubmed/35939302
http://dx.doi.org/10.1001/jamanetworkopen.2022.25600

Ejemplares similares